CompBrief BY VELARION

Companies XBiotech Inc.

XBiotech CEO salary & total pay, FY2025: $571K

XBiotech (XBIT) CEO salary, fiscal 2025: Sushma Shivaswamy was paid a salary of $468,557 and $570,992 in total compensation. Free brief. Every figure links to the company’s own filing.

Velarion Intel: free for 3 days, no card →

Email me XBiotech Inc.’s executive pay brief as a PDF

You get it on this page the moment you ask; press Download and a copy goes to your email too. Every figure is cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

Also free: The Pay Desk, the weekly executive pay briefing.

Sushma Shivaswamy's complete compensation dossier

A PDF and a CSV sent to your email: Sushma Shivaswamy's pay in every fiscal year XBiotech Inc. reported it, line by line, with Sushma Shivaswamy's equity grants and XBiotech Inc.'s disclosed peer group where the company discloses them. Every row is cited to its filing.

One-time report. No refunds.

See an example →
CEO total pay$570,992CEO Sushma Shivaswamy · source
Say-on-pay support88.12%Latest vote · source
CEO pay ratio345:1To the median employee · source

CEO pay, last three years

  • $5,556,481FY2023
  • $6,245,581FY2024
  • $570,992FY2025

CEO total pay was $570,992 in fiscal 2025 (Sushma Shivaswamy), down from $6,245,581 in fiscal 2024 (John Simard, the CEO that year).

FY2025: salary $468,557 · bonus $90,000 · stock awards $0 · option awards $0

Executives and directors

Frequently asked questions

Who was the highest-paid executive at XBiotech Inc. in fiscal 2025?
As disclosed, John Simard (Former President & Chief Executive Officer) was the highest-paid executive at XBiotech Inc. in fiscal 2025, with total compensation of $30,134,204.
What is XBiotech Inc.'s CEO-to-median employee pay ratio?
As disclosed, XBiotech Inc.'s CEO-to-median employee pay ratio was 345:1.
How did shareholders vote on XBiotech Inc.'s executive compensation?
As disclosed, 88.12% of shareholders supported XBiotech Inc.'s executive compensation in the latest say-on-pay vote.
How much does XBiotech Inc. spend in total on board compensation for fiscal 2025?
As disclosed, XBiotech Inc. reported total board compensation of $471,288 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
John Simard$1,250,000$8,530,442$0$3,000,000$0$0$17,353,762$30,134,204
Former President & Chief Executive Officer
Sushma Shivaswamy468,55790,000000012,436570,992
Interim Chief Executive Officer & Chief Scientific Officer
Angela Hu200,00040,00000005,419245,419
Director of Finance

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
John Simard$30,134,204$6,245,581$5,556,481↑ +23,888,623
Sushma Shivaswamy570,992657,572720,499↓ −86,580
Angela Hu245,419285,419—↓ −40,000

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

The Company's executive compensation program is designed to enable it to attract and retain key executives who are critical to the Company's future success and creation of shareholder value. The program seeks to enhance shareholder value by aligning the financial interests of executive officers with those of shareholders and to motivate and reward executives whose knowledge, skills, and performance are critical to success.

CEO STI target (% of salary)—
CEO LTI target (% of salary)—
Independent consultant—
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
Equity grants and outstanding awards

No plan-based awards are on file for this fiscal year.

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardExercisableShares unvestedExercise priceMarket value unvested
Angela HuOption5,000—5.26—
Angela HuOption10,000—10.36—
Angela HuOption10,000—12.64—
Angela HuOption30,000—3.84—
John SimardOption48,125—9.45—
John SimardOption61,516—4.24—
John SimardOption110,740—4.44—
John SimardOption150,000—7.45—
John SimardOption500,000—11.12—
John SimardOption1,026,228—3.52—
Sushma ShivaswamyOption50,000—4.24—
Sushma ShivaswamyOption150,000—4.13—
Sushma ShivaswamyOption15,000—5.26—
Sushma ShivaswamyOption100,000—10.36—
Sushma ShivaswamyOption100,000—12.67—
Sushma ShivaswamyOption100,000—3.84—
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Craig RademakerIndependent · Audit · Compensation · Nominating and Corporate Governance (Chair) · Partial-year service$73,260—$163,156—$0$236,417
Thomas KündigIndependent · Compensation (Chair) · Nominating and Corporate Governance · Partial-year service62,795—140,147—0202,942
Tevi TroyIndependent · Audit (Chair) · Partial-year service33,973—99,200—0133,173
Jan-Paul WaldinIndependent · Not standing for re-election · Departed during FY105,644—23,976—0129,620
David SofferIndependent · Audit · Partial-year service30,575—90,343—0120,919
Peter LibbyIndependent · Not standing for re-election · Departed during FY85,836—23,976—0109,812
Tak MakIndependent · Not standing for re-election · Departed during FY · Partial-year service46,219—23,976—070,195
W.Thorpe McKenzieIndependent · Not standing for re-election · Departed during FY32,986—0—032,986

Board fee structure and ownership guideline

Annual cash retainer$50,000
Annual equity retainer—
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)—
Stock ownership guideline—

Total cost of the board

ComponentFY2025
Cash retainers and fees$471,288
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$471,288

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names XBiotech as a peer

Companies that benchmark against XBIT

1 company names XBIT as a compensation peer

Each company listed discloses XBIT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named XBIT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1XBiotech Inc.2025Sushma Shivaswamy$468,557$0$0$0$570,992

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20252025-08-2911,336,5001,460,49868,13488.12%Passed
20242024-06-20—————
20232023-06-23—————
20222022-06-22—————
20202020-06-26—————
20192019-06-19—————

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
20252025-08-2988.12%a
20242024-06-20—b
20232023-06-23—c

a. Approved under the standard stated in the filing — “• To be approved, Proposal 3, the advisory approval of the Company's executive compensation must receive "For" votes from the holders of a majority of shares present and entitled to vote either in person or represented by proxy. || Abstentions: If you mark your proxy to "Abstain" from voting, it will have the same effect as an "Against" vote.”.

b. Voting standard not stated in the filing.

c. Voting standard not stated in the filing.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

CEO pay ratio

Ratio (CEO : median employee)345 : 1
CEO total compensation$30,102,697
Median employee compensation$87,096
Insider trades since the proxy

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
John SimardDirector2026-10-26A368,524$2$711,251CommonForm 4 ↗
John SimardCo-Chief Executive Officer2026-10-26A2,000,00000Derivative, Class A CommonForm 4 ↗
John SimardDirector2026-11-03A70,0002143,409CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

Sources (21 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, John Simard. DEF 14A, filed 2026-10-02. Section “Executive Compensation”. As printed: 30,134,204. View filing ↗
  • Section 01, Sushma Shivaswamy. DEF 14A, filed 2026-10-02. Section “Executive Compensation”. As printed: 570,992. View filing ↗
  • Section 01, Angela Hu. DEF 14A, filed 2026-10-02. Section “Executive Compensation”. As printed: 245,419. View filing ↗
  • Section 07, pay ratio. DEF 14A, filed 2026-10-02. Section “CEO Pay Ratio”. As printed: 345 : 1. View filing ↗
  • Section 08, Craig Rademaker. DEF 14A, filed 2026-10-02. Section “Director Compensation”. As printed: 236,417. View filing ↗
  • Section 08, Thomas Kündig. DEF 14A, filed 2026-10-02. Section “Director Compensation”. As printed: 202,942. View filing ↗
  • Section 08, Tevi Troy. DEF 14A, filed 2026-10-02. Section “Director Compensation”. As printed: 133,173. View filing ↗
  • Section 08, Jan-Paul Waldin. DEF 14A, filed 2026-10-02. Section “Director Compensation”. As printed: 129,620. View filing ↗
  • Section 08, David Soffer. DEF 14A, filed 2026-10-02. Section “Director Compensation”. As printed: 120,919. View filing ↗
  • Section 08, Peter Libby. DEF 14A, filed 2026-10-02. Section “Director Compensation”. As printed: 109,812. View filing ↗
  • Section 08, Tak Mak. DEF 14A, filed 2026-10-02. Section “Director Compensation”. As printed: 70,195. View filing ↗
  • Section 08, W.Thorpe McKenzie. DEF 14A, filed 2026-10-02. Section “Director Compensation”. As printed: 32,986. View filing ↗
  • Section 02, John Simard 2026-10-26. Form 4, filed 2026-10-28. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John Simard 2026-10-26. Form 4, filed 2026-10-28. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John Simard 2026-11-03. Form 4, filed 2026-11-13. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 06, 2025 vote. Form 8-K, filed 2025-09-02. Item 5.07 · say-on-pay result. As reported: 88.12% (votes for as printed: 11,336,500). View filing ↗
  • Section 06, 2024 vote. Form 8-K, filed 2024-06-20. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
  • Section 06, 2023 vote. Form 8-K, filed 2023-06-23. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
  • Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
  • Section 09b board cost (computed). Computed. Cash 471,288 + equity 0 + all other 0 = 471,288, summed across the director compensation table rows.
  • XBiotech Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-10-02. CEO total compensation as printed in XBiotech Inc.'s own proxy. As printed: 570,992. View filing ↗
Get the full report — $299